Price Sarah A, Gorelik Alexandra, Fourlanos Spiros, Colman Peter G, Wentworth John M
Walter and Eliza Hall Institute, 1G Royal Parade, Parkville 3050, Australia.
Obes Res Clin Pract. 2014 Mar-Apr;8(2):e178-82. doi: 10.1016/j.orcp.2013.03.007.
Excessive body weight is increasingly seen in type 1 diabetes but its impact is debated. To address this uncertainty, we aimed to determine the association between excess body weight and the macro- and microvascular complications of type 1 diabetes. We identified 501 adults with type 1 diabetes attending an Australian hospital clinic and extracted their clinical and biochemical data from our patient management database. In both men and women, obesity (BMI > 30 kg/m(2)) was the predominant risk factor for retinopathy and cardiovascular disease despite similar HbA1c and increased use of cardioprotective drugs compared to non-obese patients. Obesity was associated with albuminuria in women, but not renal impairment or neuropathy in either sex. We conclude that obesity in type 1 diabetes may promote retinopathy and macrovascular disease. Future trials to determine the effect of weight loss on type 1 diabetes in obese people are needed.
1型糖尿病患者中体重超标现象日益常见,但其影响仍存在争议。为解决这一不确定性,我们旨在确定超重与1型糖尿病大血管和微血管并发症之间的关联。我们纳入了501名在澳大利亚医院门诊就诊的1型糖尿病成年患者,并从我们的患者管理数据库中提取了他们的临床和生化数据。在男性和女性中,尽管与非肥胖患者相比糖化血红蛋白(HbA1c)相似且心脏保护药物使用增加,但肥胖(体重指数[BMI]>30kg/m²)仍是视网膜病变和心血管疾病的主要危险因素。肥胖与女性蛋白尿相关,但与两性的肾功能损害或神经病变无关。我们得出结论,1型糖尿病患者肥胖可能会促进视网膜病变和大血管疾病。未来需要进行试验以确定减肥对肥胖的1型糖尿病患者的影响。